FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

(2012) Dariusz Pytel et al.   Anti-Cancer Agents in Medicinal Chemistry

Resist or die: FOXO transcription factors determine the cellular response to chemotherapy

(2011) Ana R. Gomes et al.   CELL CYCLE

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

(2010) Roque Diaz et al.   BMC CANCER

Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence

(2010) D. R. Littler et al.   NUCLEIC ACIDS RESEARCH

Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma

(2010) Kondo   ONCOLOGY REPORTS

Angiogenesis and Lymphangiogenesis of Gastric Cancer

(2010) Yasuhiko Kitadai   Journal of Oncology

Foxo1 is essential for in vitro vascular formation from embryonic stem cells

(2009) Seung-Hwan Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

(2009) Marja Lohela et al.   CURRENT OPINION IN CELL BIOLOGY

The role of angiogenesis in solid tumours: An overview

(2009) Nektaria Makrilia et al.   European Journal of Internal Medicine

FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol

(2009) Rakesh K. Srivastava et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

(2009) L. Jain et al.   MOLECULAR CANCER THERAPEUTICS

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

(2009) U. B. McGovern et al.   MOLECULAR CANCER THERAPEUTICS

BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3

(2008) A. Nordigarden et al.   BLOOD

FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells

(2008) Yujian Zhang et al.   CANCER RESEARCH

VEGFPolymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer

(2008) Rebecca Suk Heist et al.   JOURNAL OF CLINICAL ONCOLOGY

The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression

(2008) R. C.-Y. Hui et al.   MOLECULAR AND CELLULAR BIOLOGY

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

(2008) Silvia Fernández de Mattos et al.   MOLECULAR CANCER THERAPEUTICS

Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression

(2008) J. M-M. Kwok et al.   MOLECULAR CANCER THERAPEUTICS

Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells

(2008) R. C-Y. Hui et al.   MOLECULAR CANCER THERAPEUTICS

S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons

(2008) Alexi Nott et al.   NATURE

A brief introduction to FOXOlogy

(2008) B M Th Burgering   ONCOGENE

FOXO animal models reveal a variety of diverse roles for FOXO transcription factors

(2008) K C Arden   ONCOGENE

The FoxO code

(2008) D R Calnan et al.   ONCOGENE

Many forks in the path: cycling with FoxO

(2008) K K Ho et al.   ONCOGENE

FOXOs, cancer and regulation of apoptosis

(2008) Z Fu et al.   ONCOGENE

OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins

(2008) Kenneth Maiese et al.   TRENDS IN MOLECULAR MEDICINE

FOXO3a Turns the Tumor Necrosis Factor Receptor Signaling Towards Apoptosis Through Reciprocal Regulation of c-Jun N-Terminal Kinase and NF-κB

(2007) Hae-Young Lee et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY